You have 9 free searches left this month | for more free features.

Condition

Membranous Nephropathy (2)

antiPLA2R Positive (2)

Glomerulonephritis (1)

Glomerulonephritis, Membranous (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

phase 1/phase 2 (1)

Sponsor

MorphoSys AG (2)

Mario Negri Institute for Pharmacological Research (1)

Collaborator

MorphoSys AG (1)

Intervention

mor202 (3)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

mor202

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Membranous Nephropathy Trial in Bergamo, Ranica (MOR202)

Recruiting

Membranous Nephropathy

MOR202

Bergamo, BG, Italy
+1 more

Mar 4, 2022

Glomerulonephritis, Membranous Nephropathy, antiPLA2R Positive Trial in Worldwide (MOR202)

Active, not recruiting

Glomerulonephritis
+2 more

MOR202

Tbilisi, Georgia
+24 more

Aug 23, 2022

Glomerulonephritis, Membranous, antiPLA2R Positive Trial in Worldwide (MOR202)

Completed

Glomerulonephritis, Membranous
antiPLA2R Positive

MOR202

Azusa, California
+44 more

Dec 12, 2022